Patents by Inventor Daniel DeSantis

Daniel DeSantis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210386825
    Abstract: The present invention provides microparticles that induce the migration of multipotent stem cells to the anatomical site of the microparticles. Various release profiles are demonstrated that depend upon the relative concentration of alginate in the chemokine-loaded microparticle. Local administration and/or intraarticular injection of the microparticles are useful in conditions such as osteoarthritis. Targeted systemic delivery of the alginate chemokine microparticles to distant anatomical sites subjected to autoimmune disease symptomology can be performed by encapsulation within liposomes having targeting ligands. Consequently, upon the creation of the appropriate chemokine gradient, multipotent stem cells will migrate to the distant anatomical site where the liposomes are attached.
    Type: Application
    Filed: August 30, 2021
    Publication date: December 16, 2021
    Applicants: UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, Ri.MED Foundation
    Inventors: Steven R. Little, Riccardo Gottardi, Mintai Peter Hwang, Daniel DeSantis
  • Patent number: 11129875
    Abstract: The present invention provides microparticles that induce the migration of multipotent stem cells to the anatomical site of the microparticles. Various release profiles are demonstrated that depend upon the relative concentration of alginate in the chemokine-loaded microparticle. Local administration and/or intraarticular injection of the microparticles are useful in conditions such as osteoarthritis. Targeted systemic delivery of the alginate chemokine microparticles to distant anatomical sites subjected to autoimmune disease symptomology can be performed by encapsulation within liposomes having targeting ligands. Consequently, upon the creation of the appropriate chemokine gradient, multipotent stem cells will migrate to the distant anatomical site where the liposomes are attached.
    Type: Grant
    Filed: January 7, 2019
    Date of Patent: September 28, 2021
    Assignees: UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, RI.MED FOUNDATION
    Inventors: Steven R. Little, Riccardo Gottardi, Mintai Peter Hwang, Daniel DeSantis
  • Publication number: 20190209651
    Abstract: The present invention provides microparticles that induce the migration of multipotent stem cells to the anatomical site of the microparticles. Various release profiles are demonstrated that depend upon the relative concentration of alginate in the chemokine-loaded microparticle. Local administration and/or intraarticular injection of the microparticles are useful in conditions such as osteoarthritis. Targeted systemic delivery of the alginate chemokine microparticles to distant anatomical sites subjected to autoimmune disease symptomology can be performed by encapsulation within liposomes having targeting ligands. Consequently, upon the creation of the appropriate chemokine gradient, multipotent stem cells will migrate to the distant anatomical site where the liposomes are attached.
    Type: Application
    Filed: January 7, 2019
    Publication date: July 11, 2019
    Inventors: Steven R. Little, Riccardo Gottardi, Mintai Peter Hwang, Daniel DeSantis
  • Patent number: 10195252
    Abstract: The present invention provides microparticles that deliver in vivo predictable release profiles of at least one chemokine to create a biomimetic chemokine concentration gradient that induces the migration of multipotent stem cells to the anatomical site of the microparticles. Various release profiles are demonstrated that depend upon the relative concentration of alginate in the chemokine-loaded microparticle. Local administration and/or intraarticular injection of the microparticles are useful in conditions such as osteoarthritis. Targeted systemic delivery of the alginate chemokine microparticles to distant anatomical sites subjected to autoimmune disease symptomology can be performed by encapsulation within liposomes having targeting ligands. Consequently, upon the creation of the appropriate chemokine gradient, multipotent stem cells will migrate to the distant anatomical site where the liposomes are attached.
    Type: Grant
    Filed: August 1, 2013
    Date of Patent: February 5, 2019
    Assignee: University Of Pittsburgh—Of The Commonwealth System of Higher Education
    Inventors: Steven R. Little, Riccardo Gottardi, Mintai Peter Hwang, Daniel DeSantis
  • Patent number: 9856941
    Abstract: A flywheel system including a rotor shaft. The rotor shaft includes an inner passage therethrough, and a dam with a central opening disposed on a first end of the inner passage. An outer passage surrounds the inner passage. The inner passage is open at a second end, and the outer passage is closed on an end surrounding the second end of the inner passage. The outer passage is open on an end surrounding the first end of the inner passage. Fluid flows into the inner passage at the first end, via the central opening of the dam. Rotation of the flywheel rotor causes the fluid to accumulate along a wall of the inner passage, and to propagate to the second end, where the fluid exits into the outer passage. The fluid propagates along the outer passage to the open end of the outer passage, where it is released.
    Type: Grant
    Filed: July 8, 2015
    Date of Patent: January 2, 2018
    Assignee: Beacon Power, LLC
    Inventors: James Arseneaux, David Ansbigian, Daniel DeSantis, Norman Brackett
  • Publication number: 20170009845
    Abstract: A flywheel system including a rotor shaft. The rotor shaft includes an inner passage therethrough, and a dam with a central opening disposed on a first end of the inner passage. An outer passage surrounds the inner passage. The inner passage is open at a second end, and the outer passage is closed on an end surrounding the second end of the inner passage. The outer passage is open on an end surrounding the first end of the inner passage. Fluid flows into the inner passage at the first end, via the central opening of the dam. Rotation of the flywheel rotor causes the fluid to accumulate along a wall of the inner passage, and to propagate to the second end, where the fluid exits into the outer passage. The fluid propagates along the outer passage to the open end of the outer passage, where it is released.
    Type: Application
    Filed: July 8, 2015
    Publication date: January 12, 2017
    Applicant: BEACON POWER, LLC
    Inventors: James Arseneaux, David Ansbigian, Daniel DeSantis, Norman Brackett